{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:03:08Z","timestamp":1787727788550,"version":"build-2784847793"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T00:00:00Z","timestamp":1635292800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003995","name":"Natural Science Foundation of Anhui Province","doi-asserted-by":"publisher","award":["1808085MH261"],"award-info":[{"award-number":["1808085MH261"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81372475"],"award-info":[{"award-number":["81372475"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002947","name":"Anhui Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Oncolytics"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.omto.2021.10.009","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T20:02:20Z","timestamp":1635451340000},"page":"387-401","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["RUNX1\/EGFR pathway contributes to STAT3 activation and tumor growth caused by hyperactivated mTORC1"],"prefix":"10.1016","volume":"23","author":[{"given":"Wei","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0172-3617","authenticated-orcid":false,"given":"Anjiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5713-4446","authenticated-orcid":false,"given":"Meng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2937-130X","authenticated-orcid":false,"given":"Xu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8828-4228","authenticated-orcid":false,"given":"Zixi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianguo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9546-6203","authenticated-orcid":false,"given":"Juan","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4006-0748","authenticated-orcid":false,"given":"Xiaojun","family":"Zha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omto.2021.10.009_bib1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41580-019-0199-y","article-title":"mTOR at the nexus of nutrition, growth, ageing and disease","volume":"21","author":"Liu","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.omto.2021.10.009_bib2","doi-asserted-by":"crossref","first-page":"31189","DOI":"10.1073\/pnas.2017152117","article-title":"Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis","volume":"117","author":"Yi","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.omto.2021.10.009_bib3","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/s41568-018-0074-8","article-title":"mTOR signalling and cellular metabolism are mutual determinants in cancer","volume":"18","author":"Mossmann","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.omto.2021.10.009_bib4","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/iub.1579","article-title":"Tuberous sclerosis complex: from molecular biology to novel therapeutic approaches","volume":"68","author":"Switon","year":"2016","journal-title":"IUBMB Life"},{"key":"10.1016\/j.omto.2021.10.009_bib5","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/ncb839","article-title":"TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling","volume":"4","author":"Inoki","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.omto.2021.10.009_bib6","doi-asserted-by":"crossref","first-page":"8313","DOI":"10.1074\/jbc.C500451200","article-title":"TSC1 stabilizes TSC2 by inhibiting the interaction between TSC2 and the HERC1 ubiquitin ligase","volume":"281","author":"Chong-Kopera","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omto.2021.10.009_bib7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41556-018-0205-1","article-title":"mTOR as a central hub of nutrient signalling and cell growth","volume":"21","author":"Kim","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.omto.2021.10.009_bib8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/cancers9050052","article-title":"Epidermal growth factor receptor cell proliferation signaling pathways","volume":"9","author":"Wee","year":"2017","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.omto.2021.10.009_bib9","doi-asserted-by":"crossref","first-page":"103811","DOI":"10.1016\/j.bioorg.2020.103811","article-title":"A review on progression of epidermal growth factor receptor (EGFR) inhibitors as an efficient approach in cancer targeted therapy","volume":"99","author":"Ayati","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.omto.2021.10.009_bib10","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1038\/s41388-021-01841-2","article-title":"Receptor tyrosine kinases and cancer: oncogenic mechanisms and therapeutic approaches","volume":"40","author":"Saraon","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.omto.2021.10.009_bib11","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1172\/JCI28984","article-title":"PDGFRs are critical for PI3K\/Akt activation and negatively regulated by mTOR","volume":"117","author":"Zhang","year":"2007","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omto.2021.10.009_bib12","doi-asserted-by":"crossref","first-page":"54858","DOI":"10.18632\/oncotarget.18963","article-title":"Hyperactivated mTORC1 downregulation of FOXO3a\/PDGFRalpha\/AKT cascade restrains tuberous sclerosis complex-associated tumor development","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.omto.2021.10.009_bib13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.canlet.2015.01.001","article-title":"NFkappaB up-regulation of glucose transporter 3 is essential for hyperactive mammalian target of rapamycin-induced aerobic glycolysis and tumor growth","volume":"359","author":"Zha","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.omto.2021.10.009_bib14","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1172\/JCI91788","article-title":"Genetic regulation of the RUNX transcription factor family has antitumor effects","volume":"127","author":"Morita","year":"2017","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omto.2021.10.009_bib15","doi-asserted-by":"crossref","first-page":"6423","DOI":"10.1038\/s41598-018-24969-w","article-title":"RUNX1 positively regulates the ErbB2\/HER2 signaling pathway through modulating SOS1 expression in gastric cancer cells","volume":"8","author":"Mitsuda","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omto.2021.10.009_bib16","doi-asserted-by":"crossref","first-page":"29689","DOI":"10.18632\/oncotarget.8822","article-title":"The transcription factor RUNX2 regulates receptor tyrosine kinase expression in melanoma","volume":"7","author":"Boregowda","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.omto.2021.10.009_bib17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1158\/0008-5472.CAN-10-1668","article-title":"Lactate dehydrogenase B is critical for hyperactive mTOR-mediated tumorigenesis","volume":"71","author":"Zha","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.omto.2021.10.009_bib18","first-page":"1713","article-title":"Regulation of mTORC1 and its impact on gene expression at a glance","volume":"126","author":"Laplante","year":"2013","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.omto.2021.10.009_bib19","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMra055323","article-title":"The tuberous sclerosis complex","volume":"355","author":"Crino","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omto.2021.10.009_bib20","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev-genom-083118-015354","article-title":"Genetic etiologies, diagnosis, and treatment of tuberous sclerosis complex","volume":"20","author":"Salussolia","year":"2019","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1016\/j.omto.2021.10.009_bib21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1172\/JCI37964","article-title":"Mammalian target of rapamycin regulates murine and human cell differentiation through STAT3\/p63\/Jagged\/Notch cascade","volume":"120","author":"Ma","year":"2010","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omto.2021.10.009_bib22","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1126\/science.aad0489","article-title":"mTORC1 induces purine synthesis through control of the mitochondrial tetrahydrofolate cycle","volume":"351","author":"Ben-Sahra","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.omto.2021.10.009_bib23","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.cmet.2018.11.006","article-title":"The circadian protein Period2 suppresses mTORC1 activity via recruiting Tsc1 to mTORC1 complex","volume":"29","author":"Wu","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.omto.2021.10.009_bib24","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1073\/pnas.1014769108","article-title":"Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth","volume":"108","author":"Sun","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.omto.2021.10.009_bib25","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/iub.2232","article-title":"Upregulation of 6-phosphofructo-2-kinase (PFKFB3) by hyperactivated mammalian target of rapamycin complex 1 is critical for tumor growth in tuberous sclerosis complex","volume":"72","author":"Wang","year":"2020","journal-title":"IUBMB Life"},{"key":"10.1016\/j.omto.2021.10.009_bib26","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.3390\/cancers7030860","article-title":"Targeting RTK signaling pathways in cancer","volume":"7","author":"Regad","year":"2015","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.omto.2021.10.009_bib27","doi-asserted-by":"crossref","first-page":"e3558","DOI":"10.1371\/journal.pone.0003558","article-title":"Anti-EGFR antibody efficiently and specifically inhibits human TSC2-\/- smooth muscle cell proliferation. Possible treatment options for TSC and LAM","volume":"3","author":"Lesma","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.omto.2021.10.009_bib28","doi-asserted-by":"crossref","first-page":"315240","DOI":"10.1155\/2015\/315240","article-title":"Anti-EGFR antibody reduces lung nodules by inhibition of EGFR-pathway in a model of lymphangioleiomyomatosis","volume":"2015","author":"Lesma","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.omto.2021.10.009_bib29","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11060-019-03310-z","article-title":"Ecotropic viral integration site 1 regulates EGFR transcription in glioblastoma cells","volume":"145","author":"Mizuguchi","year":"2019","journal-title":"J.\u00a0Neurooncol."},{"key":"10.1016\/j.omto.2021.10.009_bib30","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1128\/MCB.06152-11","article-title":"TIEG1 inhibits breast cancer invasion and metastasis by inhibition of epidermal growth factor receptor (EGFR) transcription and the EGFR signaling pathway","volume":"32","author":"Jin","year":"2012","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.omto.2021.10.009_bib31","first-page":"225","article-title":"Transcriptional control of epidermal growth factor receptor by retinoic acid","volume":"3","author":"Zheng","year":"1992","journal-title":"Cell Growth Differ."},{"key":"10.1016\/j.omto.2021.10.009_bib32","doi-asserted-by":"crossref","first-page":"7446","DOI":"10.1093\/nar\/gkq634","article-title":"A novel role of CPEB3 in regulating EGFR gene transcription via association with Stat5b in neurons","volume":"38","author":"Peng","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omto.2021.10.009_bib33","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1016\/j.bbrc.2018.08.071","article-title":"Transcriptional activation of EGFR by HOXB5 and its role in breast cancer cell invasion","volume":"503","author":"Lee","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omto.2021.10.009_bib34","doi-asserted-by":"crossref","first-page":"R61","DOI":"10.1186\/bcr1767","article-title":"Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a potential target for therapy","volume":"9","author":"Stratford","year":"2007","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.omto.2021.10.009_bib35","doi-asserted-by":"crossref","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-06-0626","article-title":"Mechanisms of EGFR gene transcription modulation: relationship to cancer risk and therapy response","volume":"12","author":"Brandt","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omto.2021.10.009_bib36","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.1021\/acs.jmedchem.1c00120","article-title":"Discovery of pyrrole-imidazole polyamides as PD-L1 expression inhibitors and their anticancer activity via immune and nonimmune pathways","volume":"64","author":"Wang","year":"2021","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.omto.2021.10.009_bib37","doi-asserted-by":"crossref","first-page":"e2695","DOI":"10.1038\/cddis.2017.86","article-title":"The mTOR signal regulates myeloid-derived suppressor cells differentiation and immunosuppressive function in acute kidney injury","volume":"8","author":"Zhang","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.omto.2021.10.009_bib38","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.bbrc.2019.09.042","article-title":"The mTOR-RUNX1 pathway regulates DC-SIGN expression in renal tubular epithelial cells","volume":"519","author":"Zhou","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omto.2021.10.009_bib39","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.4049\/jimmunol.1900769","article-title":"RNA-binding protein HuR promotes Th17 cell differentiation and can be targeted to reduce autoimmune neuroinflammation","volume":"204","author":"Chen","year":"2020","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.omto.2021.10.009_bib40","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1042\/BJ20111464","article-title":"Ornithine decarboxylase mRNA is stabilized in an mTORC1-dependent manner in Ras-transformed cells","volume":"442","author":"Origanti","year":"2012","journal-title":"Biochem. J."},{"key":"10.1016\/j.omto.2021.10.009_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08977194.2018.1473393","article-title":"STAT3: a multifaceted oncoprotein","volume":"36","author":"Guanizo","year":"2018","journal-title":"Growth Factors"},{"key":"10.1016\/j.omto.2021.10.009_bib42","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nrc3818","article-title":"Revisiting STAT3 signalling in cancer: new and unexpected biological functions","volume":"14","author":"Yu","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.omto.2021.10.009_bib43","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1365-2443.2011.01575.x","article-title":"Phospho-Ser727 of STAT3 regulates STAT3 activity by enhancing dephosphorylation of phospho-Tyr705 largely through TC45","volume":"17","author":"Wakahara","year":"2012","journal-title":"Genes Cells"},{"key":"10.1016\/j.omto.2021.10.009_bib44","doi-asserted-by":"crossref","first-page":"16158","DOI":"10.1073\/pnas.0702596104","article-title":"Activation of the PTEN\/mTOR\/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance","volume":"104","author":"Zhou","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.omto.2021.10.009_bib45","doi-asserted-by":"crossref","first-page":"6552","DOI":"10.1074\/jbc.M112.418335","article-title":"Gadd45a suppresses tumor angiogenesis via inhibition of the mTOR\/STAT3 protein pathway","volume":"288","author":"Yang","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omto.2021.10.009_bib46","doi-asserted-by":"crossref","first-page":"25756","DOI":"10.1074\/jbc.M115.665208","article-title":"Brain-expressed X-linked 2 is pivotal for hyperactive mechanistic target of rapamycin (mTOR)-mediated tumorigenesis","volume":"290","author":"Hu","year":"2015","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omto.2021.10.009_bib47","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1124\/mol.109.057042","article-title":"Signal transducer and activator of transcription 3 is required for abnormal proliferation and survival of TSC2-deficient cells: relevance to pulmonary lymphangioleiomyomatosis","volume":"76","author":"Goncharova","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.omto.2021.10.009_bib48","doi-asserted-by":"crossref","first-page":"919","DOI":"10.7150\/jca.33696","article-title":"miR-125b-5p\/STAT3 pathway regulated by mTORC1 plays a critical role in promoting cell proliferation and tumor growth","volume":"11","author":"Zhang","year":"2020","journal-title":"J.\u00a0Cancer"},{"key":"10.1016\/j.omto.2021.10.009_bib49","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0960-9822(99)00268-7","article-title":"Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR","volume":"10","author":"Yokogami","year":"2000","journal-title":"Curr. Biol."},{"key":"10.1016\/j.omto.2021.10.009_bib50","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1517\/14728222.2012.710200","article-title":"Ron receptor tyrosine kinase signaling as a therapeutic target","volume":"16","author":"Benight","year":"2012","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.omto.2021.10.009_bib51","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s41419-021-03433-0","article-title":"AKT1-CREB stimulation of PDGFRalpha expression is pivotal for PTEN deficient tumor development","volume":"12","author":"Wan","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.omto.2021.10.009_bib52","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1084\/jem.20131080","article-title":"Estradiol and mTORC2 cooperate to enhance prostaglandin biosynthesis and tumorigenesis in TSC2-deficient LAM cells","volume":"211","author":"Li","year":"2014","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.omto.2021.10.009_bib53","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"10.1016\/j.omto.2021.10.009_bib54","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: a web\u00a0server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Res."}],"container-title":["Molecular Therapy Oncolytics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2372770521001467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2372770521001467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T12:32:35Z","timestamp":1784723555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2372770521001467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":54,"alternative-id":["S2372770521001467"],"URL":"https:\/\/doi.org\/10.1016\/j.omto.2021.10.009","relation":{},"ISSN":["2372-7705"],"issn-type":[{"value":"2372-7705","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RUNX1\/EGFR pathway contributes to STAT3 activation and tumor growth caused by hyperactivated mTORC1","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Oncolytics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omto.2021.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors.","name":"copyright","label":"Copyright"}]}}